Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Health Insurance Innovations (HIIQ) Has 'Significant Upside' in Sale - Canaccord Genuity
-
HyreCar to Present at Investor Conferences in August
-
Canaccord Genuity Starts CRISPR Therapeutics (CRSP) at Buy
-
Leaf Group to Participate at the 39th Annual Canaccord Genuity Growth Conference
-
Leaf Group to Participate at the 39th Annual Canaccord Genuity Growth Conference
-
Neuronetics to Present at the 39th Annual Canaccord Genuity Growth Conference
-
Neuronetics to Present at the 39th Annual Canaccord Genuity Growth Conference
-
SPS Commerce Reports Second Quarter 2019 Financial Results
-
SPS Commerce Reports Second Quarter 2019 Financial Results
-
TransMedics to Present at the 39th Annual Canaccord Genuity Global Growth Conference
-
GenMark Diagnostics to Participate in the Canaccord Genuity Growth Conference
-
Itron to Present at Oppenheimer’s 22nd Annual Technology, Internet and Communications Conference and Canaccord Genuity’s 39th Annual Growth Conference
-
Synacor to Present at Canaccord Genuity’s 39th Annual Growth Conference
-
Senseonics to Participate in the Canaccord Genuity Growth Conference
-
TransMedics to Present at the 39th Annual Canaccord Genuity Global Growth Conference
-
GenMark Diagnostics to Participate in the Canaccord Genuity Growth Conference
-
Castle Biosciences Inc. (CSTL) IPO Opens 25% Higher
-
Livongo Health (LVGO) IPO Opens 45% Higher
-
Evolent Health to Participate in Upcoming Investor Conference
-
Boston Scientific to Participate in 39th Annual Canaccord Genuity Growth Conference
-
Upland Software to Present at the 39th Annual Canaccord Genuity Growth Conference
-
CryoLife to Present at Canaccord Genuity 39th Annual Growth Conference
-
Inseego Corp. to Participate in the Canaccord Genuity 39th Annual Growth Conference
-
HTG Molecular to Present Corporate Overview at the Canaccord Genuity 39th Annual Growth Conference
-
Golden Predator Completes $9.3 Million Private Placement
-
Halozyme To Participate In 39th Annual Canaccord Genuity Growth Conference
-
Tesla (TSLA) PT Lowered to $350 at Canaccord Genuity
-
ServiceNow (NOW) PT Raised to $315 at Canaccord Genuity
-
LeMaitre Vascular (LMAT) PT Raised to $29 at Canaccord Genuity
-
iRobot Corporation (IRBT) PT Lowered to $75 at Canaccord Genuity
-
Facebook (FB) PT Raised to $240 at Canaccord Genuity
-
Cerner (CERN) PT Raised to $80 at Canaccord Genuity
-
Form 8.3 - [Accesso Technology Group plc (for CGWL)]
-
Livongo Health, Inc. (LVGO) Prices 12.687M Share IPO at $28/Sh
-
Castle Biosciences Inc. (CSTL) Prices 4M Share IPO at $16/Sh
-
Net Asset Value(s)
-
Castle Biosciences Announces Pricing of Initial Public Offering
-
Livongo Announces Pricing of Initial Public Offering
-
Livongo Announces Pricing of Initial Public Offering
-
POSaBIT Announces Updated Brokered Private Placement
-
Astronics Corporation to Present at Canaccord Genuity Global Growth Conference
-
Chembio Diagnostics to Participate in the Canaccord Genuity Growth Conference
-
iRhythm Technologies to Present at the 39th Annual Canaccord Genuity Global Growth Conference
-
Insulet to Present at Upcoming Investor Conferences
-
Strategic Metals Ltd. Closes Fully Subscribed Private Placement
-
Canaccord Genuity Downgrades Thomson Reuters (TRI) to Sell
-
ORBCOMM CEO to Present at the Canaccord Genuity 39th Annual Growth Conference
-
ORBCOMM CEO to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Rezolute Completes $45 Million Investment Round with Full Exercise of $20 Million Option
-
Rezolute Completes $45 Million Investment Round with Full Exercise of $20 Million Option

